Circulating tumor DNA alterations in patients with metastatic castration‐resistant prostate cancer

Author:

Sonpavde Guru1,Agarwal Neeraj2,Pond Gregory Russell3,Nagy Rebecca J.4,Nussenzveig Roberto H.2ORCID,Hahn Andrew W.2ORCID,Sartor Oliver5,Gourdin Theodore Stewart6,Nandagopal Lakshminarayanan7,Ledet Elisa M.5,Naik Gurudatta7ORCID,Armstrong Andrew J.8ORCID,Wang Jue9,Bilen Mehmet Asim10ORCID,Gupta Shilpa11,Grivas Petros12,Pal Sumanta K.13ORCID,Lanman Richard B.4ORCID,Talasaz AmirAli4,Lilly Michael B.6

Affiliation:

1. Dana‐Farber Cancer Institute Boston Massachusetts

2. Huntsman Cancer Institute, University of Utah Salt Lake City Utah

3. Ontario Clinical Oncology Group Hamilton Ontario Canada

4. Guardant Health Inc Redwood City California

5. Tulane University New Orleans Louisiana

6. Hollings Cancer Center Medical University of South Carolina Charleston South Carolina

7. University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama

8. Duke Cancer Center Durham North Carolina

9. University of Arizona Cancer Center at Dignity Health St. Joseph’s Hospital and Medical Center Phoenix Arizona

10. Winship Cancer Institute, Emory University Atlanta Georgia

11. University of Minnesota Minneapolis Minnesota

12. University of Washington Seattle Washington

13. City of Hope Comprehensive Cancer Center Duarte California

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3